Matches in Nanopublications for { ?s ?p "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP209336.RAApPFXnMRKUraAd1x7SkkaVP2zlzsTrqcduEE-U3qgS0130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209336.RAApPFXnMRKUraAd1x7SkkaVP2zlzsTrqcduEE-U3qgS0130_provenance.
- NP893436.RAZ0gW3mvVNfYtXAI4zK-ETxb-Mrw-wMQJpRV_ythIhZ4130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893436.RAZ0gW3mvVNfYtXAI4zK-ETxb-Mrw-wMQJpRV_ythIhZ4130_provenance.
- NP999078.RAScimbqcHXlAPf8PJyFIoqgAGGdsM0mTBb9EBFsSewZ4130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999078.RAScimbqcHXlAPf8PJyFIoqgAGGdsM0mTBb9EBFsSewZ4130_provenance.
- NP999079.RAeoSMoDCwmX5tQPBR_Q9RFij08JMjSVvsbrqbnZICme8130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999079.RAeoSMoDCwmX5tQPBR_Q9RFij08JMjSVvsbrqbnZICme8130_provenance.
- NP253238.RAr0pCiRI1b-04XRkeTvhxp-IKqWAsG7F6B32seBPWfmk130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253238.RAr0pCiRI1b-04XRkeTvhxp-IKqWAsG7F6B32seBPWfmk130_provenance.
- NP893493.RAtDkEvAcCP0JPFdN8CtivxOUOa0L7xg79LZlCUXaphuk130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893493.RAtDkEvAcCP0JPFdN8CtivxOUOa0L7xg79LZlCUXaphuk130_provenance.
- NP999076.RAkLwIR3Jh8Y4eHfL84XHd7-qtal6eNwUjkcqkbwGCHLQ130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999076.RAkLwIR3Jh8Y4eHfL84XHd7-qtal6eNwUjkcqkbwGCHLQ130_provenance.
- NP253157.RAzQyriOCrT1O6_g7dF40P05i5MIsnJAY1ypd8YK9ycj0130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253157.RAzQyriOCrT1O6_g7dF40P05i5MIsnJAY1ypd8YK9ycj0130_provenance.
- NP999077.RALFq-Kw1at6hG36EQVsK-WWfnGHT22pbcm8IeZM4AIA4130_assertion description "[The prevalence of low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells, cannot exclude HSIL (ASC-H) in the study population were 22.1%, 30.9%, 0.6%, 13.5% and 4.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP999077.RALFq-Kw1at6hG36EQVsK-WWfnGHT22pbcm8IeZM4AIA4130_provenance.